The U.S. Supreme Court has declined to hear an appeal from former Theranos executive Ramesh “Sunny” Balwani, leaving in place his 2022 convictions for defrauding investors and patients and his sentence of 12 years and 11 months in federal prison, according to multiple reports of the court's October 2026 order.

Source: SSBCrack News

Balwani, who served as Theranos' president and chief operating officer alongside founder Elizabeth Holmes, was convicted on all 12 counts against him — conspiracies and wire fraud involving both investors and patients. Prosecutors showed at trial that the company promoted machines said to run comprehensive blood tests from a tiny finger-prick sample when the technology could reliably handle only a limited range of tests, and that Balwani promoted the services while aware some results could be inaccurate.

Source: USFTB News

In his appeal, Balwani argued that jurors were denied important context from a 2013 investor call in which Holmes discussed a possible military use of the technology while expressing uncertainty about it. The Supreme Court rejected the challenge without taking the case, which closes his direct appeal route. He is serving his sentence at FCI Terminal Island in San Pedro, California.

Holmes, who founded Theranos in 2003, is serving a sentence of 11 years and three months for investor fraud. The two executives were ordered, jointly and individually, to pay more than $452 million in restitution. Balwani had pleaded not guilty throughout the case.

The Theranos collapse remains one of Silicon Valley's most closely watched fraud cases, and Balwani — an Indian-origin executive who became one of its central figures — has been followed closely by diaspora readers in California and beyond.